MEDIA ADVISORY / INVITATION - This Rare Disease Day, Feb. 29, CORD celebrates the launch of the Canadian Rare Disease Network - but patients will still have NO access to the promised $1.4 billion in federal funds for rare disease drugs
The federal government promised a Rare Disease Drug Strategy five years ago and announced $1.4 billion in drug funding last March. Today, not a single patient has received a single penny from that fund despite urgent unmet needs.
The uniting of healthcare professionals and patient organizations under the Canadian Rare Disease Network will accelerate patient diagnosis and specialist care ... but for many patients they will have no access to life-saving and life-altering drugs that are already approved and recommended but not yet available in public drug plans.
OTTAWA, ON, Feb. 28, 2024 /CNW/ - Patients are OUT OF PATIENCE. Along with families and health professionals, they are demanding immediate release of these funds.
WHEN:Thursday, February 29, 2024 ? the rarest day in the calendar ? 9:30 a.m.
VIDEO FEED / REMOTE QUESTIONS: Zoom link to be issued by Press Gallery prior to event
WHO:
Dr. Durhane Wong-Rieger PhD, President and CEO, Canadian Organization for Rare Disorders (CORD)
Dr. Jida El Hajjar PhD, Vice-Chair CORD Board of Directors and Executive Director of ALS Action Canada
Dr. François Bernier, Chair, Canadian Rare Disease Network; Professor, Medical Genetics and Pediatrics, University of Calgary; and Project Lead, One Child Every Child, Alberta Children's Hospital Research Institute
Madi Vanstone, rare disease patient and advocate
The press conference will be followed by a march of rare disease patients and advocates to Parliament Hill to celebrate Rare Disease Day and the launch of the Canadian Rare Disease Network, as well as to protest the lack of long-promised federal drug funding to benefit Canadians with rare diseases.
Participation in the question and answer portion of this event is in person or via Zoom, and is for accredited members of the Press Gallery only. Media who are not members of the Press Gallery may contact [email protected] for temporary access.
SOURCE CANADIAN ORGANIZATION FOR RARE DISORDERS (CORD)
On Saturday, May 11, hundreds of hikers and mountain bikers will hit the trails in China Camp State Park to raise funds and awareness about the North Bay's critical need for mental healthcare. The 3rd annual Bike + Hike 4 Buckelew is hosted by...
Vasomune Therapeutics Inc., a clinical-stage biopharmaceutical company focused on the development of AV-001 for the treatment of diseases associated with vascular dysfunction, today announced that the Company will present a Late-Breaking scientific...
NOMADX Holdings, LLC, a company pioneering new technologies for biological and chemical detection, announced today that it has initiated an early access program for its portable NOMADX platform which aims to enable faster, more accurate on-site...
Azurity Pharmaceuticals, a pharmaceutical company focused on developing innovative dose forms and formulations of products to serve the needs of overlooked patients, announced today that the U.S. Food and Drug Administration (FDA) has approved...
The board of directors of Eli Lilly and Company has declared a dividend for the second quarter of 2024 of $1.30 per share on outstanding common stock.
The dividend is payable on June 10, 2024, to shareholders of record at the close of business...
One Health Direct (OHD) leadership has continuously recognized and focused on the importance of implementing patient product awareness and eligibility education of innovative DME products for over a decade. Providing educational resources centered...